Akums Drugs (India) Market Value

AKUMS Stock   607.30  31.95  5.00%   
Akums Drugs' market value is the price at which a share of Akums Drugs trades on a public exchange. It measures the collective expectations of Akums Drugs and investors about its performance. Akums Drugs is selling at 607.30 as of the 29th of November 2024; that is 5 percent decrease since the beginning of the trading day. The stock's open price was 639.25.
With this module, you can estimate the performance of a buy and hold strategy of Akums Drugs and and determine expected loss or profit from investing in Akums Drugs over a given investment horizon. Check out Akums Drugs Correlation, Akums Drugs Volatility and Akums Drugs Alpha and Beta module to complement your research on Akums Drugs.
Symbol

Please note, there is a significant difference between Akums Drugs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akums Drugs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akums Drugs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Akums Drugs 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Akums Drugs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Akums Drugs.
0.00
10/30/2024
No Change 0.00  0.0 
In 31 days
11/29/2024
0.00
If you would invest  0.00  in Akums Drugs on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Akums Drugs and or generate 0.0% return on investment in Akums Drugs over 30 days. Akums Drugs is related to or competes with Kingfa Science, GTL, Indo Amines, Exide Industries, Delta Manufacturing, and EID Parry. Akums Drugs is entity of India. It is traded as Stock on NSE exchange. More

Akums Drugs Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Akums Drugs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Akums Drugs and upside and downside potential and time the market with a certain degree of confidence.

Akums Drugs Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Akums Drugs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Akums Drugs' standard deviation. In reality, there are many statistical measures that can use Akums Drugs historical prices to predict the future Akums Drugs' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akums Drugs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
546.57625.32628.61
Details
Intrinsic
Valuation
LowRealHigh
506.84510.13668.03
Details
Naive
Forecast
LowNextHigh
720.57723.86727.15
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
489.03723.69958.34
Details

Akums Drugs Backtested Returns

Akums Drugs secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of risk over the last 3 months. Akums Drugs and exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Akums Drugs' Standard Deviation of 3.22, risk adjusted performance of (0.12), and Mean Deviation of 2.29 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.64, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Akums Drugs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Akums Drugs is expected to be smaller as well. At this point, Akums Drugs has a negative expected return of -0.45%. Please make sure to confirm Akums Drugs' treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Akums Drugs performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.4  

Poor reverse predictability

Akums Drugs and has poor reverse predictability. Overlapping area represents the amount of predictability between Akums Drugs time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Akums Drugs price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Akums Drugs price fluctuation can be explain by its past prices.
Correlation Coefficient-0.4
Spearman Rank Test-0.71
Residual Average0.0
Price Variance1237.32

Akums Drugs lagged returns against current returns

Autocorrelation, which is Akums Drugs stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Akums Drugs' stock expected returns. We can calculate the autocorrelation of Akums Drugs returns to help us make a trade decision. For example, suppose you find that Akums Drugs has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Akums Drugs regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Akums Drugs stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Akums Drugs stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Akums Drugs stock over time.
   Current vs Lagged Prices   
       Timeline  

Akums Drugs Lagged Returns

When evaluating Akums Drugs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Akums Drugs stock have on its future price. Akums Drugs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Akums Drugs autocorrelation shows the relationship between Akums Drugs stock current value and its past values and can show if there is a momentum factor associated with investing in Akums Drugs and.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Akums Stock

Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.